COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,659 Articles (22,913 medRxiv, 8,746 bioRxiv)

Most recent first Previous |  Page 2127: Articles 21261-21270  | Next

Tracking the Dynamics and Allocating Tests for COVID-19 in Real-Time: an Acceleration Index with an Application to French Age Groups and Departments
Baunez, C., Degoulet, M., Luchini, S., Pintus, P., Teschl, M.
10.1101/2020.11.05.20226597 — Posted: 2020-11-07
Epidemiological characteristics of deaths from COVID-19: an analysis at almost three months of the first confirmed case in Peru
Ramos, W., Arrasco, J., De La Cruz-Vargas, J. A., Ordonez, L., Vargas, M., Seclen, Y., Luna, M., Guerrero, N., Medina, J., Sandoval, I., Solis, E., Loayza, M.
10.1101/2020.11.05.20226639 — Posted: 2020-11-07 Discussion: Onsite
Ready for a BASE jump? Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population.
Lapidus, N., Paireau, J., Levy-Bruhl, D., de Lamballerie, X., Severi, G., Touvier, M., Zins, M., Cauchemez, S., Carrat, F., the SAPRIS-SERO study group
10.1101/2020.11.06.20227025 — Posted: 2020-11-07 Discussion: Onsite
COVID-19 Wastewater Epidemiology: A Model to Estimate Infected Populations
McMahan, C. S., Self, S., Rennert, L., Kalbaugh, C., Kriebel, D., Graves, D., Deaver, J. A., Popat, S., Karanfil, T., Freedman, D. L.
10.1101/2020.11.05.20226738 — Posted: 2020-11-07
Interventions targeting nonsymptomatic cases can be important to prevent local outbreaks: COVID-19 as a case-study
Lovell-Read, F. A., Funk, S., Obolski, U., Donnelly, C. A., Thompson, R. N.
10.1101/2020.11.06.20226969 — Posted: 2020-11-07
Validation of home oxygen saturations as a marker of clinical deterioration in patients with suspected COVID-19
Inada-Kim, M., Chmiel, F. P., Boniface, M. J., Pocock, H., Black, J. J. M., Deakin, C. D.
10.1101/2020.11.06.20225938 — Posted: 2020-11-07
Longitudinal Physiological Data from a Wearable Device Identifies SARS-CoV-2 Infection and Symptoms and Predicts COVID-19 Diagnosis
Hirten, R. P., Danieletto, M., Tomalin, L., Choi, K. H., Zweig, M., Golden, E., Kaur, S., Helmus, D., Biello, A., Pyzik, R., Nabeel, I., Charney, A., Glicksberg, B. S., Levin, M., Reich, D., Charney, D., Bottinger, E. P., Keefer, L., Suarez-Farinas, M., Nadkarni, G. N., Fayad, Z. A.
10.1101/2020.11.06.20226803 — Posted: 2020-11-07 Discussion: Onsite
Kinetics of viral load, immunological mediators and characterization 1 of a SARS-CoV-2 isolate in mild COVID-19 patients during acute phase of infection
Anantharaj, A., Gujjar, S., Kumar, S., Jain, N., Wangchuk, J., Khan, N. A., Panwar, A., Kanakan, A., A, V., Vasudevan, J. S., Das, A., Pandey, A. K., Pandey, R., Medigeshi, G. R.
10.1101/2020.11.05.20226621 — Posted: 2020-11-07
Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of New York City Metro Blood Donors using Multiple SARS-CoV-2 Serological Assays: Implications for Controlling the Epidemic and Reopening.
Jin, D. K., Nesbitt, D. J., Yang, J., Chen, H., Horowitz, J., Jones, M., Vandergaast, R., Carey, T., Reiter, S., Russell, S. J., Kyratsous, C., Hooper, A., Hamilton, J., Ferreira, M., Deng, S., Straus, D., Baras, A., Hillyer, C. D., Luchsinger, L. L.
10.1101/2020.11.06.20220087 — Posted: 2020-11-07
Predicting the impact of disruptions in lymphatic filariasis elimination programmes due to the outbreak of coronavirus disease (COVID-19) and possible mitigation strategies
Prada, J. M., Stolk, W. A., Davis, E. L., Touloupou, P., Sharma, S., Munoz, J., Caja Rivera, R. M., Reimer, L. J., Michael, E., de Vlas, S. J., Hollingsworth, D.
10.1101/2020.11.06.20227017 — Posted: 2020-11-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).